Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

The prognostic significance of the ball-valve effect in Groshong catheters

  • 40 Accesses

  • 6 Citations

Abstract

The aim of the work was to determine the prognostic significance of the ball-valve effect (BVE) in a population of adult cancer patients with long-term indwelling Groshong catheters. A prospective longitudinal study of 356 Groshong catheters utilized for long-term central venous access was carried out in adult oncology patients. A subset analysis was undertaken of those catheters that developed BVE. BVE was the most commonly identified impediment to normal catheter function, comprising 30% of all identified complications (119/397). BVE was also the most frequent de novo (primary) complication (85 of 221, 38.5%), as well as the complication that occurred soonest in the life of the catheter (average=61.2 days after insertion). Patients with BVE were likely to develop subsequent catheter-related venous thrombosis (20 of 30 compared to 65 of 191,P<0.01), but no other significant catheter-related complication. Patients more than 65 years old had an increased incidence of BVE as the primary complication (46 of 85 compared to 49 of 136,P=0.01), while patients with breast cancer had a lower incidence (12 of 85 compared to 36 of 136,P=0.04). No catheter was removed as a result of the development of BVE. The onset of BVE represents an elemental perturbation of catheter function which portends the development of other, more significant vascular occlusive complications. Phenomenologically, BVE has been overshadowed in significance by the clinically more dramatic venous thrombosis and catheter-related infections. The true significance of BVE can not be determined until the impact of preventing this early complication on the incidence of secondary complications is analyzed prospectively.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Bandyk DF (1990) Deep vein thrombosis and thrombophlebitis. In: Rakel RE (ed) Conn's current therapy. Saunders, Philadelphia, pp 301–305

  2. 2.

    Bern MM, Lokich JJ, Wallach SR, et al (1990) Very low doses of warfarin can prevent thrombosis in central venous catheters — a randomized prospective trial. Ann Intern Med 112:243

  3. 3.

    Delmore JE, Jack BL, Roberts DK (1989) Experience with the Groshong long-term central venous catheter. Gynecol Oncol 34:216–218

  4. 4.

    Denny DF (1993) Placement and management of long-term central venous access catheters and ports. Am J Roentgenol 161:385–393

  5. 5.

    Fleiss DL (1981) Statistical methods for rates and proportions. Wiley, New York

  6. 6.

    Gleeson NC, Fiorica JV, Mark JE, et al (1993) Externalized Groshong catheters and Hickman ports for central venous access in gynecologic oncology patients. Gynecol Oncol 51:372–376

  7. 7.

    Gould JR (1995) Catheter related venous thrombosis—reply (letter). Am J Med 98:99–100

  8. 8.

    Gould JR, Carloss HW, Skinner WL (1993) Groshong catheter-associated subclavian venous thrombosis. Am J Med 95:418–423

  9. 9.

    Groeger JS, Lucas AB, Coit D (1991) Venous access in the cancer patient. Princ Pract Oncol Updates 5:1–13

  10. 10.

    Groeger JS, Lucas AB, Thaler HT, et al (1993) Infectious morbidity associated with long-term use of venous access devices in patients with cancer. Ann Intern Med 119:1168–1174

  11. 11.

    Haire WE, Leiberman RP, Edney J, et al (1990) Hickman catheter-induced thoracic vein thrombosis. Cancer 66:900–908

  12. 12.

    Haire WD, Lieberman RP, Lund GB, et al (1991) Thrombotic complications of silicone rubber catheters during autologous marrow and peripheral stem cell transplantation: prospective comparison of Hickman and Groshong catheters. Bone Marrow Transplant 7:57–59

  13. 13.

    Hull JE, Hunter CS, Luiken GA (1992) The Groshong catheter: initial experience and early results of imaging-guided placement. Radiology 185:637–638

  14. 14.

    Kamal GD, Pfaller MA, Rempe LE, et al (1991) Reduced intravascular infection by antibiotic bonding. JAMA 265:2364–2368

  15. 15.

    Keung YK, Watkins K, Chen SC, et al (1993) Comparative study of infectious complications of different types of chronic central venous access devices. Gynecol Oncol 51:372–376

  16. 16.

    Land W, Schweiger H, Richter U, et al (1992) Hickman catheter for longterm parenteral therapy. A prospective interdisciplinary study. Med Klin 87:412–417

  17. 17.

    Malviya VK, Deppe G, Gove N, et al (1989) Vascular access in gynecologic cancer using the Groshong right atrial catheter. Gynecol Oncol 33:313–316

  18. 18.

    Mirro J Jr, Rao BN, Stokes DC, et al (1989) A prospective study of Hickman/Broviac catheters and implantable ports in pediatric oncology patients. J Clin Oncol 7:214–222

  19. 19.

    Newman KA, Reed WP, Schimpff SC, et al (1993) Hickman catheters in association with intensive cancer chemotherapy. Support Care Cancer 1:92–97

  20. 20.

    Pasquale MD, Campbell JM, Magnant CM (1992) Groshong versus Hickman catheters. Surg Gynecol Obstet 174:408–410

  21. 21.

    Rubin RN (1983) Local installation of small doses of streptokinase for treatment of thrombotic occlusions of long-term access catheters. J Clin Oncol 1:572–573

  22. 22.

    Salzman EW, Deykin D, Shapiro RM, et al (1975) Management of heparin therapy: controlled prospective trial. N Engl J Med 292:1046–1050

  23. 23.

    Shaw C, Newcomer L, Young J (1989) Efficacy of Groshong catheters for oncology patients (abstract). Proc Annu Meet Am Soc Clin Oncol 8: A1305

  24. 24.

    Simon C, Suttorp M (1994) Results of antibiotic treatment of Hickman-catheter-related infections in oncological patients. Support Care Cancer 2:66–70

  25. 25.

    Spiers ASD (1989) Primary cutaneous infections withcandida species associated with percutaneous intravenous catheters in patients with cancer. J Fla Med Assoc 76:386–387

  26. 26.

    Stanley HD, Charlebois E, Harb G, et al (1994) Central venous catheter infections in AIDS patients receiving treatment for cytomegalovirus disease. J Acquired Immune Defic Syndrome 7:272–278

  27. 27.

    Taber's cyclopedic medical dictionary, 14th edn (1981) Davis, Philadelphia

  28. 28.

    Tschirhart JM, Rao MK (1988) Mechanism and management of persistent withdrawal occlusion. Am Surg 54:326–328

  29. 29.

    Van Hoff J, Berg AT, Seashore JH (1990) The effect of right atrial catheters on infectious complications of chemotherapy in children. J Clin Oncol 8:1255–1262

  30. 30.

    Williams N, Carlson GL, Scott NA, et al (1994) Incidence and management of catheter-related sepsis in patients receiving home parenteral nutrition. Br J Surg 81:392–394

  31. 31.

    Yokoyama S, Fujimoto T, Tajima T, et al (1988) Use of Broviac/Hickman catheter for long-term venous access in pediatric patients. Jpn J Clin Oncol 18:143–148

Download references

Author information

Additional information

This study was supported in part by Bard Access Systems, Salt Lake City, Utah

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Tolar, B., Gould, J.R. The prognostic significance of the ball-valve effect in Groshong catheters. Support Care Cancer 4, 34–38 (1996). https://doi.org/10.1007/BF01769873

Download citation

Key words

  • Cancer
  • Groshong
  • Catheter
  • Complications
  • Venous access